Aimfinity Investment Corp. I filed its 10-Q showing modest non-operating profits and significant balance sheet changes typical of a SPAC nearing its deadline. For the six months ended June 30, 2025, the company reported net income of $75,425, driven by $484,941 of interest on trust assets and $409,516 of formation and operating costs. For Q2, net income was $10,494.
Trust assets were $13,981,534 as of June 30, 2025, after the redemption of 1,996,522 Class A shares for $23,778,577. 1,116,476 ordinary shares were classified as redeemable at $12.52 each. Working capital showed a deficit of $2,515,028, and management disclosed “substantial doubt” about continuing as a going concern absent a business combination by the extended deadline.
The company continues to pursue its merger with Docter Inc. It converted $1,500,000 of sponsor loans into 150,000 private units on April 8, 2025, and restructured deferred IPO underwriting fees on June 13, 2025 to $80,000 cash plus 132,875 PubCo shares for each underwriter at closing. Extensions funded through deposits push the combination window to October 28, 2025.
Aimfinity Investment Corp. I called an extraordinary general meeting for October 27, 2025 to vote on three items: extending its deadline to complete the Docter Business Combination and permitting up to nine one‑month extensions to July 28, 2026; removing the $5,000,001 net tangible asset redemption floor; and a potential adjournment to gather more votes.
If the extension is approved, the Sponsor would deposit $500 into the trust for each monthly extension. As of the September 29, 2025 record date, the trust held approximately $14.29 million. The company estimates a redemption price of about $12.80 per share, subject to the trust’s actual value at redemption. Shareholders may redeem by submitting New Units; the Class 2 warrants attached to redeemed New Units will be forfeited.
Approval of the two amendments requires a two‑thirds special resolution of Class A and Class B shares voting together. If the extension is not approved and no business combination is completed by October 28, 2025, the company states it will redeem public shares and liquidate.
Aimfinity Investment Corp. I is changing how it will acquire Inkrock Holding Limited in connection with its planned business combination with Docter Inc. The company and related parties terminated a prior May 27, 2025 securities purchase agreement that would have transferred all of CEO I-Fa Chang’s Inkrock securities to PubCo in exchange for the immediate issuance of 687,054 ordinary shares.
Because that earlier transfer was never completed, the parties signed a termination agreement on October 6, 2025 and a new securities purchase agreement on October 7, 2025. Under the new arrangement, the same 687,054 ordinary shares will be issued to the seller, and all Inkrock securities will be transferred to PubCo, but both steps will occur simultaneously with the closing of the approved business combination, as an unregistered sale of equity securities.
Aimfinity Investment Corp. I is asking shareholders to approve a charter amendment that would extend its period to complete a business combination to October 28, 2025 and permit the Board, at the Sponsor's request, to approve up to nine additional one-month extensions through July 28, 2026. The company entered into a Merger Agreement with Docter Inc. that contemplates a reincorporation merger into a Cayman Islands PubCo and an acquisition merger resulting in PubCo as the surviving public company.
The proxy explains redemption mechanics: public shareholders may redeem shares for a pro rata cash amount from the Trust Account (including interest) if the Charter Amendment is approved, with attached Class 2 warrants forfeited on redemption. The filing discloses Trust Account funding from the IPO (gross proceeds cited at $80.5 million and $82,110,000 placed in trust) and that an F-4 related to the Docter Business Combination was declared effective by the SEC.
Aimfinity Investment Corp. I entered into a new unsecured promissory note of $55,823.8 on September 28, 2025 with I-Fa Chang, the designee of its sponsor, to fund a required deposit into its trust account.
This deposit of $55,823.8 equals $0.05 per public share for a one-month extension and allows Aimfinity to extend the deadline to complete its business combination with Docter Inc. from September 28, 2025 to October 28, 2025. This is the last of up to nine monthly extensions permitted under its charter.
Under an exchange agreement, the outstanding balance of the Extension Note will automatically convert into PubCo ordinary shares at $10.00 per share upon closing of the business combination, unless repaid earlier. The note was issued as an unregistered security under Section 4(a)(2) of the Securities Act, and the company furnished a press release announcing the new extension.